SCHEMBL10025641

SCHEMBL10025641

CC(COCC(OCC(C)OC(=O)c1ccccc1C(=O)c1ccccc1)C(OCC(C)OC(=O)c1ccccc1C(=O)c1ccccc1)C(C)OCC(C)OC(=O)c1ccccc1C(=O)c1ccccc1)OC(=O)c1ccccc1C(=O)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
L3MBTL1 Q9Y468 3/20 0.37
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
AKR1C3 P42330 1/20 0.36
TSHR P16473 1/20 0.36
SCN1A P35498 2/20 0.36
SCN2A Q99250 2/20 0.36
SCN3A Q9NY46 2/20 0.36
LMNA P02545 2/20 0.36
CYP2D6 P10635 1/20 0.36
CRHBP P24387 1/20 0.34
CRHR2 Q13324 1/20 0.34
ABCB1 P08183 2/20 0.34
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9906968 0.80 ALDH1A1 (0.48) ALDH1A1L3MBTL1CYP1A2CYP3A4CYP2C9
SCHEMBL28201247 0.75 ALDH1A1 (0.52) ALDH1A1L3MBTL1CYP1A2CYP3A4CYP2C9
SCHEMBL1255193 0.72 LMNA (0.54) ALDH1A1CYP1A2TSHRSCN1ASCN2A
SCHEMBL9456728 0.71 CRHBP (0.56) ALDH1A1L3MBTL1CYP1A2CYP3A4CYP2C9
SCHEMBL12287440 0.71 ALDH1A1 (0.40) ALDH1A1L3MBTL1CYP1A2CYP3A4CYP2C9
SCHEMBL5603341 0.71 ALDH1A1 (0.48) ALDH1A1L3MBTL1CYP3A4TSHRSCN1A
SCHEMBL5602707 0.71 ALDH1A1 (0.48) ALDH1A1L3MBTL1CYP3A4TSHRSCN1A
SCHEMBL14947114 0.70 ALDH1A1 (0.62) ALDH1A1CYP1A2TSHRSCN1ASCN2A
SCHEMBL9906969 0.70 ALDH1A1 (0.47) ALDH1A1L3MBTL1CYP1A2CYP3A4CYP2C9
SCHEMBL26338929 0.69 ALDH1A1 (0.65) ALDH1A1CYP1A2CYP3A4TSHRSCN1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9701762-B2 Hybrid photoinitiators BASF SE (DE) 2017-07-11 US disclosed
US-20160168279-A1 HYBRID PHOTOINITIATORS BASF SE (DE) 2016-06-16 US disclosed
US-8426484-B2 Liquid photoinitiator blend BASF SE (DE) 2013-04-23 US disclosed
US-20120035292-A1 LIQUID PHOTOINITIATOR BLEND BASF SE (DE) 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160168279-A1 HYBRID PHOTOINITIATORS CHRM1, CHRM2, CHRM3 ALDH1A1 2527/4885L3MBTL1 406/4885CYP1A2 332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.